Key facts
- Limber’s last known valuation is $12.0M (Jun 2025).
- It has raised $4.2M; the latest was Seed Round ($3.8M) in Jun 2025.
- Notable investors include National Institutes of Health, University of California, CONNECT (San Diego), Institute for the Global Entrepreneur, San Diego — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Limber
- ·The full record, as it builds
Funding rounds
No funding rounds for Limber are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Limber
Developer of prosthetic and orthotic devices designed to support the healthcare industry. The company specializes in utilizing three-dimensional printing technology to develop prosthetic and orthotic products, eliminating the need for manual manufacturing and assembly, enabling clients to obtain personalized prosthetic limbs at a lower cost.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2020
- Employees
- 9
- Website
- limberprosthetics.com/
- Ownership
- Privately Held (backing)
Limber doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Limber shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Limber in its N-PORT filings yet. We sweep new filings monthly.